| 1 |
Sampath Rangarajan |
Nec Laboratories America |
9 |
| 2 |
Bharat Kumar |
IBM |
7 |
| 3 |
Zhigang Hao |
Colgate-Palmolive |
6 |
| #4 |
Hui Cheng |
Sri International |
4 |
| #4 |
Veena Warikoo |
Genzyme |
4 |
| #4 |
James Galloway |
Omrix Biopharmaceuticals |
4 |
| #4 |
Kun Wang |
ExxonMobil |
4 |
| #4 |
Satish Pulapura |
Tyrx |
4 |
| #4 |
George Blandino |
AT&T |
4 |
| #10 |
Maximiliano Rodriguez |
PepsiCo |
3 |
| #10 |
Bo Asp Andersen |
Meta |
3 |
| #10 |
William Strohl |
Merck |
3 |
| #10 |
Jia Hua Xiao |
Johnson & Johnson |
3 |
| #14 |
Brian M. Weiss |
ExxonMobil |
2 |
| #14 |
Mohit Atul Kothare |
Signal Pharmaceuticals |
2 |
| #14 |
Xiaolei Gao |
Merck |
2 |
| #14 |
Vivek Venugopalan |
RTX (Raytheon) |
2 |
| #14 |
Xing Sun |
Jiangsu Hengrui Medicine Co. |
2 |
| #14 |
Praveen Venkataramu |
Cellco Partnership |
2 |
| #14 |
Brendan P. Flood |
— |
2 |
| #14 |
Shane Deighton |
ExxonMobil |
2 |
| #14 |
Paul S. Westbrook |
Ofs Fitel |
2 |
| #14 |
Konstantin Konstantinov |
Genzyme |
2 |
| #14 |
Scott Thompson |
Ingersoll-Rand |
2 |
| #14 |
Gilles Bignan |
Johnson & Johnson |
2 |
| #14 |
Marcus Harte |
Longitude |
2 |
| #14 |
Naresh B. Patel |
Illinois Tool Works |
2 |
| #14 |
Siddhartha Dalal |
— |
2 |
| #14 |
Amitkumar Patel |
Cisco |
2 |
| #14 |
Niranjan N. Ratnakar |
Samsung |
2 |
| #14 |
Richard F. Stockel |
Nevada Naturals |
2 |
| #14 |
David C. Nielsen |
Caci, Inc.—Federal |
2 |
| #14 |
Peter R. Rogina |
Worldscape |
2 |
| #14 |
Ronald Siwoff |
— |
2 |
| #14 |
Shane A. Lacy |
Johnson & Johnson |
2 |
| #14 |
Uri Herzberg |
Johnson & Johnson |
2 |
| #14 |
Anguel Nikolov |
Nanoopto |
2 |
| #14 |
Chao Chen |
Delta Electronics |
2 |
| #39 |
Renuka Pradhan |
— |
1 |
| #39 |
Justus Hierneis |
Corn Products Development |
1 |
| #39 |
Toma Milouchev |
Prysmian S.P.A. |
1 |
| #39 |
Sreedhar Potturi |
Optum |
1 |
| #39 |
Eckhard Kemmann |
— |
1 |
| #39 |
Tarl Vetter |
Genzyme |
1 |
| #39 |
Thomas Lee Craven |
Johnson & Johnson |
1 |
| #39 |
Peter Pechan |
Genzyme |
1 |
| #39 |
Jozsef Karman |
Genzyme |
1 |
| #39 |
Wen-Jui Li |
AT&T |
1 |
| #39 |
Jiaxin Liang |
Senex Biotechnology |
1 |
| #39 |
Thomas Hultsch |
Regeneron Pharmaceuticals |
1 |